Similar Clinical Outcomes in Oral TXA vs Epsilon-Aminocaproic Acid Up to 30 Days After THA Surgery
How to Cite
OrthoEvidence. Similar Clinical Outcomes in Oral TXA vs Epsilon-Aminocaproic Acid Up to 30 Days After THA Surgery. ACE Report. 2021;21(1):3. Available from: https://myorthoevidene.com/AceReport/Report/13446
Tranexamic acid versus aminocapróic acid in multiple doses via the oral route for the reduction of postoperative bleeding in total primary hip arthroplasty: a prospective, randomized, double-blind, controlled studyBlood Coagul Fibrinolysis. 2021 Mar 1;32(2): 132-139.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
One hundred and two patients scheduled to undergo an elective cementless primary unilateral total hip arthroplasty (THA) to treat either osteoarthritis, osteonecrosis of femoral head or developmental dysplasia of hip were randomized to receive either oral tranexamic acid (TXA) or oral epsilon-aminocaproic acid (EACA) which were both administered pre-operatively (2h pre-incision) and at 6 and 12 ho...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE